Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|15|9|1134-1140

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.15, Iss.9, 2015-01, pp. : 1134-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration

By Liao Sheng-Jun  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 853-863

Springer Publishing Company

Access to resources Recommend Favorite

Recent Patents in Toll-like Receptor Pathways and Relevance to Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 189-195

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor-2 and -4 are associated with hyperlipidemia

By            

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8241-8246

Spandidos Publications

Access to resources Recommend Favorite

Activation of Toll-like receptor 7 inhibits the proliferation and migration, and induces the apoptosis of pancreatic cancer cells

By                  

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 6079-6085

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration

By            

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 483-488

Spandidos Publications

Access to resources Recommend Favorite